Bavarian Nordic Provides Update on Business Activities and Reports Preliminary Interim Financial Results for the First Nine Months of 2014
October 22, 2014 01:45 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Partnering negotiations ongoing for the...
Bavarian Nordic opdaterer på forretningsaktiviter og fremlægger foreløbige finansielle resultater for de første ni måneder af 2014
October 22, 2014 01:45 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Igangværende partnerforhandlinger omkring...
Bavarian Nordic A/S - Articles of Association
October 20, 2014 07:24 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Updated Articles of Association for Bavarian...
Bavarian Nordic A/S - Vedtægter
October 20, 2014 07:24 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Opdaterede vedtægter for Bavarian Nordic A/S ...
Bavarian Nordic issues Financial Calendar for 2015
September 23, 2014 02:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGAARD, Denmark, September 23, 2014 -...
Bavarian Nordic offentliggør finanskalender for 2015
September 23, 2014 02:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGÅRD, Danmark - 23. september 2014 -...
Bavarian Nordic Announces Exercise of Contract Option by the U.S. Government for Continued Supply of IMVAMUNE(r) Smallpox Vaccine
September 04, 2014 12:18 ET
|
Bavarian Nordic A/S
KVISTGAARD, Denmark, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Biomedical Advanced Research and Development Authority (BARDA), a division...
Bavarian Nordic Announces Exercise of Contract Option by the U.S. Government for Continued Supply of IMVAMUNE® Smallpox Vaccine
September 04, 2014 12:12 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Option valued at USD 118 million will fund...
Bavarian Nordic offentliggør udnyttelse af option i kontrakt med den amerikanske regering om fortsatte leverancer af IMVAMUNE® koppevaccine
September 04, 2014 12:12 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Option på USD 118 mio. bidrager til...
Bavarian Nordic fremskynder udviklingen af en ny ebolavaccine i samarbejde med U.S. National Institutes of Health
September 04, 2014 00:00 ET
|
Bavarian Nordic A/S
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
KVISTGÅRD, Danmark - 4. september 2014 -...